Federal Register/Vol. 78, No. 104/Thursday, May 30, 2013/Notices
Total Page:16
File Type:pdf, Size:1020Kb
32458 Federal Register / Vol. 78, No. 104 / Thursday, May 30, 2013 / Notices Drug Schedule required to demonstrate to the Deputy with 21 CFR 1301.34, the above named Assistant Administrator, Office of company is granted registration as an Pentobarbital (2270) \ ................... II Diversion Control, Drug Enforcement importer of the basic classes of Secobarbital (2315) ...................... II Administration, that the requirements controlled substances listed. Glutethimide (2550) ...................... II for such registration pursuant to 21 Phencyclidine (7471) .................... II Dated: May 22, 2013. U.S.C. 958(a); 21 U.S.C. 823(a); and 21 Joseph T. Rannazzisi, 4-Anilino-N-phenethyl-4-piperidine II CFR 1301.34(b), (c), (d), (e), and (f) are (8333). Deputy Assistant Administrator, Office of Phenylacetone (8501) .................. II satisfied. Diversion Control, Drug Enforcement Alphaprodine (9010) ..................... II Dated: May 22, 2013. Administration. Anileridine (9020) ......................... II Joseph T. Rannazzisi, [FR Doc. 2013–12844 Filed 5–29–13; 8:45 am] Cocaine (9041) ............................. II Deputy Assistant Administrator, Office of BILLING CODE 4410–09–P Codeine (9050) ............................. II Diversion Control, Drug Enforcement Dihydrocodeine (9120) ................. II Administration. Oxycodone (9143) ........................ II DEPARTMENT OF JUSTICE Hydromorphone (9150) ................ II [FR Doc. 2013–12841 Filed 5–29–13; 8:45 am] BILLING CODE 4410–09–P Diphenoxylate (9170) ................... II Drug Enforcement Administration Hydrocodone (9193) ..................... II Levomethorphan (9210) ............... II Manufacturer of Controlled Levorphanol (9220) ...................... II DEPARTMENT OF JUSTICE Meperidine (9230) ........................ II Substances; Notice of Application; Methadone (9250) ........................ II Drug Enforcement Administration Siegfried USA, LLC Dextropropoxyphene,bulk (non- II Importer of Controlled Substances; Pursuant to § 1301.33(a), Title 21 of dosage forms) (9273). the Code of Federal Regulations (CFR), Morphine (9300) ........................... II Notice of Registration; United States Thebaine (9333) ........................... II Pharmacopeial Convention this is notice that on April 18, 2013, Oxymorphone (9652) ................... II Siegfried USA, LLC., 33 Industrial Park Alfentanil (9737) ........................... II By Notice dated March 12, 2013, and Road, Pennsville, New Jersey 08070, Sufentanil (9740) .......................... II published in the Federal Register on made application by letter to the Drug March 20, 2013, 78 FR 17230, United Enforcement Administration (DEA) to The company plans to import States Pharmacopeial Convention, be registered as a bulk manufacturer of reference standards for sale to 12601 Twinbrook Parkway, Rockville, Opium Tincture (9630), a basic class of researchers and analytical labs. Maryland 20852, made application to controlled substance listed in schedule The company plans to import the the Drug Enforcement Administration II. listed controlled substances in bulk (DEA) to be registered as an importer of The company plans to manufacture powder form from foreign sources for the following basic classes of controlled the listed controlled substance for the manufacture of analytical reference substances: distribution to its customers. standards for sale to their customers. Any other such applicant, and any Any bulk manufacturer who is Drug Schedule person who is presently registered with presently, or is applying to be, DEA to manufacture such substance, Norlevorphanol (9634) .................. I registered with DEA to manufacture may file comments or objections to the Levomethorphan (9210) ............... II issuance of the proposed registration such basic classes of controlled Difenoxin (9168) ........................... II substances listed in schedules I and II, pursuant to 21 CFR § 1301.33(a). which fall under the authority of section The company plans to import the Any such written comments or 1002(a)(2)(B) of the Act (21 U.S.C. listed controlled substances in bulk objections should be addressed, in 952(a)(2)(B)) may, in the circumstances powder form from foreign sources for quintuplicate, to the Drug Enforcement set forth in 21 U.S.C. 958(i), file the manufacture of analytical reference Administration, Office of Diversion comments or objections to the issuance standards for sale to their customers. Control, Federal Register Representative of the proposed registration and may, at No comments or objections have been (ODL), 8701 Morrissette Drive, the same time, file a written request for received. DEA has considered the Springfield, Virginia 22152; and must be a hearing on such application pursuant factors in 21 U.S.C. 823(a) and 952(a) filed no later than July 29, 2013. to 21 CFR 1301.43 and in such form as and determined that the registration of Dated: May 22, 2013. prescribed by 21 CFR 1316.47. United States Pharmacopeial Joseph T. Rannazzisi, Any such written comments or Convention to import the basic classes Deputy Assistant Administrator, Office of objections should be addressed, in of controlled substances is consistent Diversion Control, Drug Enforcement quintuplicate, to the Drug Enforcement with the public interest and with United Administration. Administration, Office of Diversion States obligations under international [FR Doc. 2013–12829 Filed 5–29–13; 8:45 am] Control, Federal Register Representative treaties, conventions, or protocols in BILLING CODE 4410–09–P (ODL), 8701 Morrissette Drive, effect on May 1, 1971. DEA has Springfield, Virginia 22152; and must be investigated United States filed no later than July 1, 2013. Pharmacopeial Convention to ensure DEPARTMENT OF JUSTICE This procedure is to be conducted that the company’s registration is simultaneously with, and independent consistent with the public interest. The Drug Enforcement Administration of, the procedures described in 21 CFR investigation has included inspection Manufacturer of Controlled 1301.34(b), (c), (d), (e), and (f). As noted and testing of the company’s physical Substances; Notice of Registration; in a previous notice published in the security systems, verification of the Sigma Aldrich Research Biochemicals, Federal Register on September 23, 1975, company’s compliance with state and Inc. 40 FR 43745–46, all applicants for local laws, and a review of the registration to import a basic classes of company’s background and history. By Notice dated February 8, 2013, and any controlled substances in schedules Therefore, pursuant to 21 U.S.C. published in the Federal Register on I or II are, and will continue to be, 952(a) and 958(a), and in accordance February 21, 2013, 78 FR 12102, Sigma VerDate Mar<15>2010 16:25 May 29, 2013 Jkt 229001 PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 E:\FR\FM\30MYN1.SGM 30MYN1 TKELLEY on DSK3SPTVN1PROD with NOTICES.